How did NUVB's EPS perform in Q4 2024 compared to previous quarters?
4/3/2025 02:41pm
Nuvation Bio (NUVB) experienced a significant improvement in its EPS in Q4 2024 compared to the previous quarter, Q3 2024. The EPS in Q4 2024 was $1.79, which is a substantial increase from the -$0.07 recorded in Q3 2024. This indicates a strong financial performance for the company in the most recent period.
|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|NUVB|NUVB.N|Nuvation Bio|2024 Q1|30|-0.07|169|
|NUVB|NUVB.N|Nuvation Bio|2024 Q2|-2000|-1.89|169|
|NUVB|NUVB.N|Nuvation Bio|2024 Q3|-66.66666666666666|-0.15|169|